1.
ACS Med Chem Lett
; 5(4): 378-83, 2014 Apr 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24900844
RESUMO
The identification and development of a novel series of small molecule Enhancer of Zeste Homologue 2 (EZH2) inhibitors is described. A concise and modular synthesis enabled the rapid development of structure-activity relationships, which led to the identification of 44 as a potent, SAM-competitive inhibitor of EZH2 that dose-dependently decreased global H3K27me3 in KARPAS-422 lymphoma cells.